Home >
News >
Register Now! 5th Translational Research E-Conference on Multiple Myeloma
Register Now! 5th Translational Research E-Conference on Multiple Myeloma
August 19, 2020
5th TRANSLATIONAL RESEARCH CONFERENCE
MULTIPLE MYELOMA
October 8-11, 2020
MOVING ONLINE!
Chairs: Kenneth C. Anderson, Maria-Victoria Mateos, Philippe Moreau
ABOUT THE E-CONFERENCE:
In view of continuing COVID-19 related challenges and uncertainties, this year’s Translational Research Conference on Multiple Myeloma will take place as a virtual event. Please note that it will begin one day earlier than initially planned, extending from October 8-11, 2020.An outstanding faculty of distinguished global experts will present the most recent advances and new perspectives in the field of Multiple Myeloma and plasma disorders, from pathophysiology to diagnosis and therapy, including current challenges and new perspectives.
The plenary E-Conference programme is designed to place emphasis on leading-edge basic and clinical research. The presentation of unpublished data is encouraged. Ample time is deliberately provided for scientific discussion and interaction.
Registered participants will further benefit from opportunities for informal scientific interaction with the world’s leading experts in the field during closed Meet the Expert sessions and E-Mentored Posters Walks.
Participants will be joining us from all over the world and from different time zones. To make sure that everyone has access to the full scientific programme at a convenient hour, registration will allow participants to join both the LIVE PROGRAMME and the PROGRAMME ON DEMAND.
MAIN TOPICS:
- Smoldering Myeloma
- Diagnosis of Multiple Myeloma
- Frontline therapy in patients not eligible for autologous Stem Cell transplantation
- Frontline therapy in patients eligible for autologous Stem Cell transplantation
- MRD and the microenvironment
- Relapsed Multiple Myeloma
- The future: recent clinical trials in relapse
- Data management issues
- Plasma Cell disorders
|
The virtual platform is already open.
Visit it now and make yourself at home!
|
TIMING OF THE SCIENTIFIC PROGRAMME:
The Virtual platform will remain open from September 29 until October 21, 2020 so that you can view and review the programme’s full scientific content at times convenient to you.
THE LIVE PROGRAMME:
Oct. 8-11, 2020, CEST time.
The whole programme will be broadcast live. All discussions and presentations requiring live scientific interaction (Meet the Expert sessions, Poster Walk) will be held live. All registered attendees, who wish to participate are invited to join us online at the indicated CEST time.
Pre-recorded lectures will be streamed live, followed by their live panel discussion (Question & Answer period) at the indicated CEST time.
THE PROGAMME ON DEMAND:
Sept. 29-Oct. 21, 2020
The pre-recorded lectures will be available “on demand” as of September 29, throughout the meeting and for ten days after it is over.
Pending the speakers’ approval, all presentations and discussions will progressively become available within the “on demand” programme so that registered attendees can freely view and review them at times convenient to them.
E-POSTERS:
Sept. 29-Oct. 21, 2020
The Poster Hall will also remain open until October 21, 2020.
The Mentored Poster Walk scheduled in the LIVE PROGRAMME will also become available in the PROGRAMME ON DEMAND.
SATELLITE SYMPOSIA LIVE AND ON DEMAND:
Symposia organized independently by our corporate partners in conjunction with the ESH meeting will also be available both Live and On Demand as described above, from Sept. 29 until Oct. 21, 2020.
VIRTUAL EXHIBITION:
Sept. 29-Oct.21,2020
We invite you to visit the e-Exhibition area as of June 20 . Our corporate partners will be pleased to welcome and chat with you.
TO ACCESS THE UPDATED PROGRAMME
CLICK HERE
TO MEET THE FACULTY
CLICK HERE
MORE INFORMATION
With the support of*:
Premium E-Conference Partner
**********
Diamond E-Conference Partner
**********
Ruby E-Conference Partners
**********
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.
